Implementation of Pharmaceutical Care in Resolving Drug Problems in Type 2 Diabetes Mellitus  

Oleh:

Tahir, Muhammad Tamrin ; Yulistiani ; Amiruddin, Rustam

Jenis: Article from Journal - ilmiah nasional - terakreditasi DIKTI
Dalam koleksi: Folia Medica Indonesiana vol. 51 no. 2 (2015), page 80-85.
Topik: diabetes mellitus; pharmaceutical care; drug related-problems; pharmacists
Fulltext: download-fullpapers-fmia7558a8621full.pdf (77.71KB)

Isi artikel

Pharmaceutical care is a comprehensive activity which aims to identify, prevent, and solve drugs problems. Treatment complexity in diabetes patients, including complications or comorbids along with the risks, increases the incidence of drug problems which can lead to clinical outcomes and health cost raising. The aim of this study was to analyze the effect of pharmaceutical implementation on drugs related problems solution in type 2 diabetes. The study was conducted in Undata General Hospital from September 2012-January 2013, an observational study with prospective data collection (n = 100). There were 120 drugs problems identified in 74 patients, the most common drug problems found in those patients were non-optimal effect of drug treatment (41%) and the interference of metformin (10%). There were 144 causes for drug problems and the most frequent was synergistic/preventive drug required and not given (13%). Among the drug problems, 76 were interfered while 44 were not. Sixty-eight interventions were done to the patient/family member, nurses and pharmacy staff with acceptance rate of 100%, 45 interventions to clinicians with acceptance rate of 69%. The results of pharmacist intervention on completion of the drug problem in 74 patients were as follows; problems not solved (8%), partially solved (7%) and totally solved (57%), while 28% received no intervention. There were differences in the amount of drug problems before and after intervention with significance of 0.000 (p < 0,05). In conclusion, the implementation of pharmaceutical care enhances drug problems solution in type 2 diabetes mellitus patients. (FMI 2015;51:80-85)

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali